MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Bayer

  1. Home
  2. Companies
  3. Bayer
  4. Clinical Trials

Clinical Trials Related to Bayer

Related studies linked through entity extraction aliases.

NCT00044915

Repinotan in Patients With Acute Ischemic Stroke

Status
COMPLETED
Phase
PHASE2

NCT00044564

Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Status
COMPLETED
Phase
PHASE2

NCT00044551

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Status
COMPLETED
Phase
PHASE2

NCT00044538

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

Status
COMPLETED
Phase
PHASE2

NCT00044525

Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients

Status
COMPLETED
Phase
PHASE2

NCT00044512

A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

Status
COMPLETED
Phase
PHASE2

NCT00034840

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Status
COMPLETED
Phase
PHASE4

NCT00031096

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Status
COMPLETED
Phase
PHASE3

NCT00002238

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.